OBRIEN MORGAN E 4
4 · Anterix Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorExecutive Chairman
Transactions
- Exercise/Conversion
Common Stock
2024-12-09$25.00/sh+90,000$2,250,000→ 113,973 total - Tax Payment
Common Stock
[F1]2024-12-09$34.05/sh−76,391$2,601,114→ 37,582 total - Exercise/Conversion
Stock Option (Right to Buy)
[F2]2024-12-09−90,000→ 0 totalExercise: $25.00Exp: 2025-01-29→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024.
- [F2]The option shares are fully vested and the option would have expired by its terms on January 29, 2025.
Signature
s/ Gena L. Ashe, Attorney-in-Fact|2024-12-11